Jubilant Therapeutics News and Activities

Jubilant Therapeutics is owned by Jubilant Bhartia Group. Jubilant Bhartia Group has a direct presence in 3 countries.

Jubilant Bhartia Group has 6 subsidiaries including HollisterStier Allergy, Jubilant Cadista and Jubilant FoodWorks.

They are in:

• Pharmaceuticals57%
• Industrial Conglomerates14%
• Other29%

View the org chart displaying its 5 main executives

Most searched biographies at Jubilant Therapeutics

• Daniel O'Connor, President and Chief Executive Officer
• Leila Alland, Director
• Sridharan Rajagopal, Senior Vice President and Head, Medicinal Che...

Popular executive movements at Jubilant Therapeutics

• Daniel O'Connor has joined the company as President and Chief Executive Officer  (posted on December 11 2025).
• Daniel O'Connor has joined the company as Chief Executive Officer, Proprietary Novel Drugs  (posted on December 2 2025).

Popular executive movements at Jubilant Bhartia Group

• Sharad Kalghatgi, Vice President of Environmental, Social and Governance and Health, Safety, has left the company  (posted on December 5 2025).
• Rahul Saini has joined the company as Group Head of Treasury  (posted on November 3 2025).
• Ankush Kuthiala has joined the company as Senior Direct Taxation Director  (posted on September 19 2025).

Click here to view some more movements at Jubilant Bhartia Group

Create your alert
to follow the executive moves at Jubilant Therapeutics.

Jubilant Bhartia Group has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Jubilant Therapeutics

• Press Releases | News - Jubilant Therapeutics
• Press Releases | News - Jubilant Therapeutics
• Press Releases | News - Jubilant Therapeutics
• Press Releases | News - Jubilant Therapeutics
• Press Releases | News - Jubilant Therapeutics

Social media about Jubilant Therapeutics

• Jubilant Therapeutics on Wikipedia, Google News & Yahoo Finance
• Jubilant Therapeutics on LinkedIn, X (Twitter) & YouTube